Calcifications on mammo could identify women at risk of CVD
Detecting breast arterial calcifications on routine mammograms could identify women at a higher risk of future cardiovascular disease (CVD), a study published March 13 in Clinical Imaging found. Researchers led by Shadi Azam, PhD, from Weill Cornell Medicine in New York found links between such calcifications and older age, diabetes, parity, younger age at first birth, and hypertension in women who underwent both screening mammography and cardiac CT angiography (CCTA). “Additionally, we found that when neither breast arterial calcifications nor coronary arterial calcifications were present, the estimated 10-year risk o...
Source: AuntMinnie.com Headlines - March 15, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news

Intrapartum Antibiotics Tied to Childhood Autoimmune Disease Intrapartum Antibiotics Tied to Childhood Autoimmune Disease
Children exposed to antibiotics during birth may be at increased risk for autoimmune disease in childhood, researchers in Finland have found.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 8, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Source Type: news

Risk for Rheumatic Disease May Rise After COVID Risk for Rheumatic Disease May Rise After COVID
While previous studies had identified a link between COVID-19 infection and greater risk for autoimmune disease, a new study is perhaps the largest and most robust to date to show an association.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 7, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news

Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2
TUESDAY, March 5, 2024 -- Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk for incident autoimmune inflammatory rheumatic disease (AIRD) compared with matched patients with influenza... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 5, 2024 Category: Pharmaceuticals Source Type: news

COVID-19 Tied to Increased Risk for Rheumatic Disease
(MedPage Today) -- Rates of new-onset autoimmune inflammatory rheumatic disease (AIRD) such as rheumatoid arthritis and systemic lupus erythematosus were significantly increased following bouts of COVID-19 in South Korea and Japan, researchers... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 4, 2024 Category: Infectious Diseases Source Type: news

GLP-1 Agonists and SGLT2 Inhibitors Do Not Increase Autoimmune Risk GLP-1 Agonists and SGLT2 Inhibitors Do Not Increase Autoimmune Risk
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease than those prescribed DPP-4 inhibitors.Medscape Medical News (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - March 4, 2024 Category: Nursing Tags: Rheumatology Source Type: news

UCLA Samueli to lead $4 million cell research project funded by Chan Zuckerberg Initiative
Key takeawaysThe grant will fund a three-year collaboration among researchers at UCLA, USC and Caltech to advance cell and tissue engineering technologies.The project, led by UCLA ’s Dino Di Carlo, will engineer, manipulate and analyze cell-to-cell interactions that underlie complex multicellular systems in the body.Di Carlo said he aims for the collaboration to develop into a long-term partnership across institutions to advance biotechnology in Los Angeles.The Chan Zuckerberg Initiativetoday announced a $4 million grant to support research led by the UCLA Samueli School of Engineering that will examine cellular behavio...
Source: UCLA Newsroom: Health Sciences - February 29, 2024 Category: Universities & Medical Training Source Type: news

Viatris partners with pharmaceutical company to commercialize 2 products
Both would address pressing cardiovascular and autoimmune diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 28, 2024 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

Sinusitis Tied to Later Autoimmune Disease
(MedPage Today) -- A history of sinus congestion and drip may be a precursor to serious autoimmune disorders, a population-based study suggested. Rates of rheumatologic conditions including antiphospholipid syndrome and Sjögren's disease... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - February 28, 2024 Category: Infectious Diseases Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news

CAR-T for Autoimmune Disease; Methods of Illegal Opioid Overdose
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 24, 2024 Category: Neurology Source Type: news

CAR T-Cell Therapy Feasible, Safe for Autoimmune Diseases
WEDNESDAY, Feb. 21, 2024 -- CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published in the Feb. 22 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2024 Category: Pharmaceuticals Source Type: news

Cushing Remission After Surgery May Raise Autoimmune Risk Cushing Remission After Surgery May Raise Autoimmune Risk
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 21, 2024 Category: Neurology Tags: Rheumatology Source Type: news

Incidence of Autoimmune Disease Increased After Surgical Remission of Cushing
TUESDAY, Feb. 20, 2024 -- Patients achieving surgical remission of Cushing disease (CD) have a higher incidence of autoimmune disease compared with those with nonfunctioning pituitary adenomas (NFPAs), according to a study published online Feb. 20... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2024 Category: Pharmaceuticals Source Type: news